COVID-19

The prevalence of long COVID has declined in the United States among the general population and people with a previously documented case of COVID-19, although many adults still report persistent symptoms, a pair of studies found.

Although both are safe and effective, the Moderna COVID-19 vaccine was linked to greater protection and a slightly lower risk for adverse events compared with the Pfizer-BioNTech vaccine in older adults, data in JAMA Network Open show.

Following SARS-CoV-2 infection, mitochondrial function remained impaired in the heart, liver and kidneys, despite observed recovery in the lungs, according to a human autopsy and animal tissue study.

The American Heart Association recently launched its first individual certification for telehealth, part of an effort to improve standards of care for a delivery model that grew exponentially — and unevenly — during the COVID-19 pandemic.

A study of SARS-CoV-2 transmission in 10 Massachusetts school districts found that the secondary attack rate of SARS-CoV-2 among school contacts was low — between 2% and 3% — and that masking reduced the odds of transmission by almost 90%.

This fall, older adults in the United States will have the opportunity to receive three vaccines to against fall and winter season respiratory illnesses — COVID-19, influenza and respiratory syncytial virus. 

The proportion of girls diagnosed with rapidly progressive central precocious puberty increased after the start of the COVID-19 pandemic compared with before the pandemic, according to a study conducted in Italy.

The rate of new cancer diagnoses among adults declined sharply in the early days of the COVID-19 pandemic, according to study results published in The Lancet Oncology.

Healio has compiled the most-read news in pulmonology posted in July.

The American College of Chest Physicians recently issued new clinical guidance on antithrombotic therapy for arterial thrombosis and thromboembolism in patients with COVID-19.